RE-BVS – Piemonte Repository

Sfoglia per AUTORE
NOZZOLI C
Collezione AOU San Luigi di Orbassano

Items : 5

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study. in Transplantation direct / Transplant Direct. 2023 Feb 22;9(3):e1451. doi: 10.1097/TXD.0000000000001451. eCollection 2023 Mar.

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Proia A; Carluccio P; Borghero C; Pavone V; Skert C; Iori AP; Luppi M; Vacca A; Falcioni S; Onida F; Bassi S; Mazza P; Nozzoli C; Maffini E; Casini M; Chiusolo P; Carella AM; Olivieri A; Terruzzi E; Natale A; De Gobbi M; Bernasconi P; Bramanti S; Grillo G; Giaccone L; Bruno B; Patriarca F; Martino M; Polverelli N; et alii...

GITMO Registry Study on Allogeneic Transplantation in Patients Aged ?60 Years from 2000 to 2017: Improvements and Criticisms. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Feb;28(2):96.e1-96.e11. doi: 10.1016/j.jtct.2021.11.006. Epub 2021 Nov 21

2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Bonifazi F; Mammoliti S; Oldani E; Ciceri F; Russo D; Selleri C; Sacchi N; Borghero C; Proia A; Skert C; Carluccio P; Pavone V; Iori AP; Falcioni S; Luppi M; Mazza P; Bassi S; Onida F; Vacca A; Nozzoli C; Casini M; Carella AM; Terruzzi E; Olivieri A; Chiusolo P; De Gobbi M; Natale A; Bramanti S; Bernasconi P; et alii...

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial. in Journal of hematology & oncology / J Hematol Oncol. 2019 Jan 9;12(1):4. doi: 10.1186/s13045-018-0691-4.

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ria R; Boccadoro M; Vacca A; Dammacco F; Petrucci MT; Musto P; Montefusco V; Rizzo M; Falcone AP; Grasso M; Gottardi D; Leonardi G; Baldini L; Benevolo G; Callea V; Patriarca F; Guglielmelli T; Nozzoli C; Larocca A; Offidani M; De Paoli L; Martino E; Bringhen S; Palumbo A; Omedè P; Giuliani N; Saltarella I; Terragna C; Morabito F; et alii...

A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma. in Leukemia / Leukemia. 2016 Jun;30(6):1320-6. doi: 10.1038/leu.2016.36. Epub 2016 Feb 22.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Sonneveld P; Offidani M; Boccadoro M; Musolino C; De Paoli L; Conticello C; Nozzoli C; Aghemo E; Derudas D; Genuardi M; Guglielmelli T; Carella AM; Ponticelli E; Spada S; Vincelli ID; De Rosa L; Omedé P; Morabito F; Montefusco V; Passera R; Benevolo G; Liberati AM; Falcone AP; Caravita T; Villani O; Oliva S; Petrucci MT; Bringhen S; et alii...

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Mar 1;32(7):634-40. doi: 10.1200/JCO.2013.52.0023. Epub 2014 Jan 21.

2014
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ria R; Offidani M; Gaidano G; Passera R; Nozzoli C; Guglielmelli T; Mina R; Morabito F; Marasca R; Omedé P; Bringhen S; Larocca A; Rossi D; Di Raimondo F; Magarotto V; Patriarca F; Levi A; Benevolo G; Vincelli ID; Grasso M; Franceschini L; Gottardi D; Zambello R; Montefusco V; Falcone AP; Palumbo A; Petrucci MT; Musto P; Boccadoro M; et alii...